Evaluates Pompe disease (glycogen storage disease type II) progression using respiratory function (FVC% predicted), muscle strength testing, and walking distance to guide enzyme replacement therapy decisions.
Evaluates Pompe disease (glycogen storage disease type II) progression using respiratory function (FVC% predicted), muscle strength testing, and walking distance to guide enzyme replacement therapy decisions
Each component has a specific meaning:
Note: Interpret the pompe progression result against the thresholds and context described above.
Enter the respiratory function, muscle strength testing, walking distance for the scenario you are assessing. Evaluates Pompe disease (glycogen storage disease type II) progression using respiratory function (FVC% predicted), muscle strength testing, and walking distance to guide enzyme replacement therapy decisions. Use the pompe progression result to inform your calculation.